Dr David Peter Choma, MD | |
300 Steam Plant Rd, Ste. 200, Gallatin, TN 37066-3032 | |
(615) 451-3929 | |
(615) 451-4845 |
Full Name | Dr David Peter Choma |
---|---|
Gender | Male |
Speciality | Nephrology |
Experience | 18 Years |
Location | 300 Steam Plant Rd, Gallatin, Tennessee |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1447307251 | NPI | - | NPPES |
1527364 | Medicaid | TN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | 42814 (Tennessee) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Fmc Portland | Portland, TN | Dialysis facility |
Fmc Hendersonville | Hendersonville, TN | Dialysis facility |
Rcg Gallatin | Gallatin, TN | Dialysis facility |
Sumner Regional Medical Center | Gallatin, TN | Hospital |
Saint Thomas West Hospital | Nashville, TN | Hospital |
Tristar Summit Medical Center | Hermitage, TN | Hospital |
Vanderbilt Wilson County Hospital | Lebanon, TN | Hospital |
Tristar Hendersonville Medical Center | Hendersonville, TN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Nephrology Associates, Pc | 0840282000 | 55 |
News Archive
New American Diabetes Association (ADA) screening guidelines may lead to the missed diagnoses of type 2 diabetes in children, according to a new study by University of Michigan.
Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 2a clinical trial that will evaluate multiple combinations of VX-770 and VX-809, investigational oral cystic fibrosis transmembrane conductance regulator (CFTR) modulators for the treatment of cystic fibrosis (CF). The trial is designed to evaluate the safety and tolerability of VX-809 dosed alone for 14 days followed by dosing of VX-809 in combination with VX-770 for 7 days.
Eating fruits and vegetables was not strongly associated with decreased colon cancer risk, according to a study published online in the September 25 Journal of the National Cancer Institute.
Health Catalyst and Partners HealthCare today announced they have been named recipients of Microsoft Corp.'s 2016 Health Innovation Awards. The organizations won the "Reinventing Productivity and Business Processes" category, which evaluates solutions that transform care delivery or population health by connecting clinicians and staff to new processes and insights.
Using a simple device for eight hours a night to treat sleep apnea can help people with prediabetes improve their blood sugar levels and may reduce the risk of progressing to diabetes, according to a new study published online in the April 21, 2015, issue of the American Journal of Respiratory and Critical Care Medicine.
› Verified 2 days ago
Entity Name | Nephrology Associates, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700878360 PECOS PAC ID: 0840282000 Enrollment ID: O20040330001670 |
News Archive
New American Diabetes Association (ADA) screening guidelines may lead to the missed diagnoses of type 2 diabetes in children, according to a new study by University of Michigan.
Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 2a clinical trial that will evaluate multiple combinations of VX-770 and VX-809, investigational oral cystic fibrosis transmembrane conductance regulator (CFTR) modulators for the treatment of cystic fibrosis (CF). The trial is designed to evaluate the safety and tolerability of VX-809 dosed alone for 14 days followed by dosing of VX-809 in combination with VX-770 for 7 days.
Eating fruits and vegetables was not strongly associated with decreased colon cancer risk, according to a study published online in the September 25 Journal of the National Cancer Institute.
Health Catalyst and Partners HealthCare today announced they have been named recipients of Microsoft Corp.'s 2016 Health Innovation Awards. The organizations won the "Reinventing Productivity and Business Processes" category, which evaluates solutions that transform care delivery or population health by connecting clinicians and staff to new processes and insights.
Using a simple device for eight hours a night to treat sleep apnea can help people with prediabetes improve their blood sugar levels and may reduce the risk of progressing to diabetes, according to a new study published online in the April 21, 2015, issue of the American Journal of Respiratory and Critical Care Medicine.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr David Peter Choma, MD 300 Steam Plant Rd, Ste. 200, Gallatin, TN 37066-3032 Ph: (615) 451-3929 | Dr David Peter Choma, MD 300 Steam Plant Rd, Ste. 200, Gallatin, TN 37066-3032 Ph: (615) 451-3929 |
News Archive
New American Diabetes Association (ADA) screening guidelines may lead to the missed diagnoses of type 2 diabetes in children, according to a new study by University of Michigan.
Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 2a clinical trial that will evaluate multiple combinations of VX-770 and VX-809, investigational oral cystic fibrosis transmembrane conductance regulator (CFTR) modulators for the treatment of cystic fibrosis (CF). The trial is designed to evaluate the safety and tolerability of VX-809 dosed alone for 14 days followed by dosing of VX-809 in combination with VX-770 for 7 days.
Eating fruits and vegetables was not strongly associated with decreased colon cancer risk, according to a study published online in the September 25 Journal of the National Cancer Institute.
Health Catalyst and Partners HealthCare today announced they have been named recipients of Microsoft Corp.'s 2016 Health Innovation Awards. The organizations won the "Reinventing Productivity and Business Processes" category, which evaluates solutions that transform care delivery or population health by connecting clinicians and staff to new processes and insights.
Using a simple device for eight hours a night to treat sleep apnea can help people with prediabetes improve their blood sugar levels and may reduce the risk of progressing to diabetes, according to a new study published online in the April 21, 2015, issue of the American Journal of Respiratory and Critical Care Medicine.
› Verified 2 days ago
Dr. Donald O. Ezuteh, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 300 Steam Plant Rd., Ste 300, Gallatin, TN 37066 Phone: 615-230-8070 Fax: 615-452-1774 | |
Dr. Jarrod Franklin Craig, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 300 Steam Plant Rd Ste 300, Gallatin, TN 37066 Phone: 615-328-4599 | |
Danielle L. Schroeder, M.D Nephrology Medicare: May Accept Medicare Assignments Practice Location: 425 E Main St, Gallatin, TN 37066 Phone: 615-452-0035 Fax: 615-452-0093 | |
Bradley S Rust, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 300 Steam Plant Road, Suite 300, Gallatin, TN 37066 Phone: 615-230-8070 Fax: 615-452-1774 | |
Dr. Guillermo S Ludi, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1720 Nashville Pike Ste 100, Gallatin, TN 37066 Phone: 615-230-8601 Fax: 615-230-8670 | |
Dr. Kevin Childers, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 300 Steam Plant Rd, Suite 300, Gallatin, TN 37066 Phone: 615-230-8070 | |
Deepti Gopichand Bulchandani, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 300 Steam Plant Rd, Suite 300 Sumner Medical Group Pllc, Gallatin, TN 37066 Phone: 615-230-8070 Fax: 615-452-1774 |